One-Stop care: hepatitis c treatment may also curb HIV and opioid abuse
NCT ID NCT03221309
First seen May 06, 2026 · Last updated May 06, 2026
Summary
This study looked at a new way to care for people who inject drugs and have hepatitis C. Along with standard hepatitis C treatment, participants were offered HIV prevention medication and medicine for opioid use disorder. The goal was to see if this combined approach could cure hepatitis C, prevent HIV, and reduce risky behaviors. 198 people took part in this pilot study.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREP are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
HIPS
Washington D.C., District of Columbia, 20002, United States
-
University of Maryland Drug Treatment Center
Batlimore, Maryland, 21223, United States
Conditions
Explore the condition pages connected to this study.